University North Carolina at Chapel Hill

Chapel Hill, North Carolina 27599

1 studies enrolling now · 4 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease, Depressive Disorder, Major, Proliferative Glomerulonephritis With Monoclonal IgG Deposits

Studies at this site

• Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide — Completed